Core Scientific, Inc. (CORZ) Income Statement
CORZ FY2025 at a glance
Fiscal year ended September 30, 2025 · U.S. dollarsCORZ revenue and net income
Where CORZ's revenue goes
FY2025Each bar shows an amount and its share of revenue. CORZ kept −90.5% of revenue as net income.
CORZ profit margins
CORZ growth rates
to FY2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −37.5% | −20.7% | +39.5% | — |
| Gross profit | −68.7% | +65.2% | +32.2% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
CORZ quarterly EPS vs estimates
Core Scientific beat the analyst EPS estimate in 1 of the last 8 quarters. Next report: November 5, 2026 (estimate $0.00).
CORZ income statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $319.0M | $510.7M | $502.4M | $640.3M | $544.5M | $60.3M | $59.5M |
| Cost of revenue | $281.1M | $389.6M | $378.9M | $631.9M | $305.6M | $50.9M | $49.0M |
| Gross profit | $37.9M | $121.1M | $123.5M | $8.4M | $238.9M | $9.4M | $10.5M |
| Research & development | — | $11.8M | $7.2M | $27.0M | $7.7M | $5.3M | $5.5M |
| Sales, general & admin | $182.6M | $120.4M | $100.9M | $226.0M | $64.5M | $14.6M | $17.5M |
| Total operating expenses | $262.4M | $140.3M | $114.5M | $884.9M | $72.2M | $15.7M | $23.0M |
| Operating income | −$224.6M | −$19.2M | $9.0M | −$244.6M | $166.6M | −$6.3M | −$11.7M |
| Interest income | $3.3M | — | — | — | — | — | — |
| Interest expense | $3.3M | $37.1M | $86.2M | $96.8M | $44.4M | $4.4M | $235,000 |
| Income before taxes | −$288.0M | −$1.31B | −$245.8M | −$2.16B | $63.1M | −$12.2M | −$11.9M |
| Income taxes | $583,000 | $859,000 | $683,000 | — | $15.8M | −$5.0M | — |
| Net income | −$288.6M | −$1.32B | −$246.5M | −$2.15B | $47.3M | −$12.2M | −$11.9M |
| EBITDA | −$207.9M | −$1.16B | −$63.1M | −$1.84B | $140.8M | $1.6M | −$5.6M |
| EPS (diluted) | −$0.50 | −$0.55 | −$0.11 | −$4.99 | $0.17 | −$0.08 | — |
| Gross margin | 11.9% | 23.7% | 24.6% | 1.3% | 43.9% | 15.6% | 17.7% |
| Operating margin | −70.4% | −3.8% | 1.8% | −38.2% | 30.6% | −10.5% | −19.6% |
| Net margin | −90.5% | −257.5% | −49.1% | −335.2% | 8.7% | −20.2% | −20.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $164.2M | $115.2M | $79.8M | $81.1M | $78.6M | $79.5M | $94.9M | $95.4M | $141.1M | $179.3M | $141.9M | $112.9M |
| Cost of revenue | $94.2M | $85.5M | $59.0M | $77.3M | $73.6M | $71.3M | $90.2M | $95.5M | $102.3M | $101.6M | $102.6M | $97.5M |
| Gross profit | $70.0M | $29.7M | $20.9M | $3.8M | $5.0M | $8.2M | $4.8M | −$156,000 | $38.8M | $77.6M | $39.3M | $15.4M |
| Research & development | — | — | — | — | — | — | $5.0M | $2.8M | $2.2M | $1.8M | $1.9M | $2.3M |
| Sales, general & admin | $49.4M | $45.2M | $16.2M | $69.4M | $56.9M | $44.6M | $38.6M | $37.5M | $26.2M | $17.9M | $28.1M | $24.6M |
| Total operating expenses | $142.2M | $53.5M | $7.9M | $69.2M | $31.3M | $55.2M | $44.5M | $41.1M | $32.2M | $22.4M | $35.4M | $27.5M |
| Operating income | −$72.1M | −$23.7M | $13.0M | −$65.4M | −$26.3M | −$47.0M | −$39.8M | −$41.2M | $6.6M | $55.2M | $3.9M | −$12.0M |
| Interest income | — | — | $916,000 | $821,000 | — | $2.2M | — | — | — | — | — | — |
| Interest expense | $23.8M | $4.9M | $916,000 | $821,000 | $1.2M | $2.2M | $1.1M | $7.1M | $14.8M | $14.1M | $83.9M | $2.2M |
| Income before taxes | −$1.15B | −$346.6M | $214.2M | −$146.5M | −$936.6M | $576.5M | −$265.2M | −$455.1M | −$804.8M | $210.9M | −$195.4M | −$41.0M |
| Income taxes | $1.9M | $600,000 | $95,000 | $125,000 | $158,000 | $205,000 | $375,000 | $134,000 | $144,000 | $206,000 | $336,000 | $114,000 |
| Net income | −$1.16B | −$347.2M | $214.2M | −$146.7M | −$936.8M | $576.3M | −$265.5M | −$455.3M | −$804.9M | $210.7M | −$195.7M | −$41.1M |
| EBITDA | −$1.11B | −$321.9M | $221.0M | −$127.4M | −$634,000 | $598.9M | −$234.9M | −$418.3M | $38.3M | $254.8M | −$80.5M | −$14.4M |
| EPS (diluted) | $0.18 | −$0.11 | −$0.18 | −$0.20 | −$0.04 | −$0.13 | −$0.13 | −$0.16 | −$0.04 | $0.16 | −$0.51 | −$0.11 |
| Gross margin | 42.7% | 25.8% | 26.2% | 4.7% | 6.4% | 10.3% | 5.0% | −0.2% | 27.5% | 43.3% | 27.7% | 13.7% |
| Operating margin | −43.9% | −20.6% | 16.3% | −80.7% | −33.4% | −59.1% | −41.9% | −43.2% | 4.7% | 30.8% | 2.8% | −10.7% |
| Net margin | −703.6% | −301.3% | 268.5% | −180.8% | −1,191.4% | 724.6% | −279.7% | −477.4% | −570.4% | 117.5% | −137.9% | −36.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CORZ's financial statements (latest annual report filed March 2, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
CORZ financial results
In fiscal year 2025 (ended September 30, 2025), Core Scientific reported revenue of $319.0 million, down 37.5% from the year before. It had a net loss of $288.6 million, a net profit margin of −90.5%. Diluted earnings per share came to −$0.50. Over five years revenue grew at an average rate of 39.5% a year.
See the CORZ stock overview for the latest quote and news, or the CORZ chart for price history and technical indicators.
CORZ income statement FAQ
What is Core Scientific's annual revenue?
Core Scientific reported total revenue of $319.0 million for fiscal year 2025, which ended on September 30, 2025. That was down 37.5% from $510.7 million the previous year.
Is Core Scientific profitable?
No. Core Scientific reported a net loss of $288.6 million in fiscal 2025, a net profit margin of −90.5%; its operating margin was −70.4%.
What is Core Scientific's gross margin?
Core Scientific's gross margin was 11.9% in fiscal 2025: for every $100 of revenue, Core Scientific kept $12 after the direct cost of its products and services.
How fast is Core Scientific growing?
Revenue grew 39.5% a year on average over the last five fiscal years, from $60.3 million to $319.0 million.
What are Core Scientific's earnings per share?
Core Scientific earned $-0.50 per diluted share in fiscal 2025, compared with $-0.55 a year earlier.
When will Core Scientific report its next earnings?
Core Scientific is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens.
When does Core Scientific's fiscal year end?
Core Scientific's fiscal year ends in September. The latest annual report covers the year ended September 30, 2025 and was filed on March 2, 2026.